ETG Lublin Sp. z o.o.
- Address
- Ul. Czarnieckiego 5, 39-200 Debica, Poland
ETG Lublin Sp. z o.o. - Multi-Specialty Clinical Research Center
ETG Lublin Sp. z o.o. is a comprehensive clinical research facility in Poland specializing in metabolic disorders, cardiovascular disease prevention, and neurological conditions. The center demonstrates particular expertise in evaluating novel therapeutic interventions across multiple therapeutic areas, with a strong focus on precision medicine and preventive healthcare approaches.
- Migraine treatment and prevention studies, including both episodic and chronic migraine management with botulinum toxin therapies
- Metabolic disease research focusing on Type 2 Diabetes Mellitus and chronic weight management in obesity
- Cardiovascular disease prevention trials targeting elevated lipoprotein(a) levels and first major cardiovascular event reduction
The research center conducts sophisticated efficacy and safety evaluations for innovative pharmacological agents, including injectable biologics, RNA interference therapeutics, and novel metabolic modulators. Their portfolio reflects a commitment to addressing major public health challenges through rigorous clinical investigation, with particular emphasis on conditions requiring long-term disease modification and preventive strategies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Amgen Inc.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ETG Lublin Sp. z o.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants with Early Parkinson’s Disease | Biohaven Therapeutics Ltd. | Phase IV | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins | 1 | Unknown | 2025-10-06 | 2025-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.